References
- Dye C. After 2015: infectious diseases in a new era of health and development. Philos Trans R Soc Lond B Biol Sci. 2014;369(1645):20130426. doi:10.1098/rstb.2013.0426.
- O’Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Rev Antimicrob Resist. 2014. http://amr-review.org/Publications
- Shen AK, Timothy Cooke M. From the analyst’s couch. Infectious disease vaccines. Nat Rev Drug Disc. 2018 Dec 19. [accessed 2019 Jan 09]. https://www.nature.com/articles/d41573-018-00011-6.
- EvaluatePharma - World Preview. 2018. Outlook to 2024, 11e – June 2018. [accessed 2019 Jan 09]. http://info.evaluategroup.com/rs/607-YGS-364/images/WP2018.pdf
- Encouraging vaccine innovation: promoting the development of vaccines that minimize the burden of infectious diseases in the 21st century. Report to Congress, U.S. Department of Health and Human Services, Dec 2017 [accessed 2019 Jan 09]. https://www.hhs.gov/sites/default/files/encouraging_vaccine_innovation_2018_final_report.pdf.
- Watson M, Faron de Goër E. Are good intentions putting the vaccination ecosystem at risk? Hum Vaccin Immunother. 2016;12(9):2469–74. doi:10.1080/21645515.2016.1172162.
- U.S. Centers for Disease Control and Prevention. Ten great public health achievements in the twentieth century, 1900–1999. [accessed 2006 Jan 6]. www.cdc.gov/od/oc/media/tengpha.htm.
- Doherty M, Buchy P, Standaert B, Giaquinto C, Prado-Cohrs D. Vaccine impact: benefits for human health. Vaccine. 2016 Dec 20;34(52):6707–14. doi:10.1016/j.vaccine.2016.10.025.
- [accessed 2019 Jan 09]. https://www.who.int/campaigns/immunization-week/2018/en/.
- Rocketing vaccine cost warning. [accessed 2019 Mar 19]. https://www.bbc.com/news/health-30853336.
- Edward RS. Jenner and the history of smallpox and vaccination. Proc (Bayl Univ Med Cent). 2005 Jan;18(1):21–25.
- Lahariya C. A brief history of vaccines & vaccination in India. Indian J Med Res. 2014 Apr;139(4):491–511.
- [accessed 2018 Nov 27]. https://www.seruminstitute.com/about_us.php.
- [accessed 2018 Sep 12]. http://www.searo.who.int/mediacentre/features/2017/india-measles-rubella-vaccination-campaign/en/.
- Taneja D, Sharma P. Targeting rubella for elimination. Indian J Public Health. 2012;56:269–72. doi:10.4103/0019-557X.106413.
- [accessed 2018 Sep 12]. http://unicef.in/Story/703/Special-World-Immunization-Week.
- Dellepiane N, Wood D. Twenty-five years of the WHOvaccines prequalification programme (1987–2012): lessons learned and future perspectives. Vaccine. 2015 Jan 1;33(1):52–61. doi:10.1016/j.vaccine.2013.11.066.
- Sharma A, Kaplan WA, Chokshi M, Zodpey SP. Role of the private sector in vaccination service delivery in India: evidence from private-sector vaccine sales data, 2009–12. Health Policy Plan. 2016 Sep;31(7):884–96. doi:10.1093/heapol/czw008.
- [accessed 2018 Sep 12]. https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=29-en-9249&alias=41210-csp29-8-e-210&Itemid=270&lang=en.
- Trotter CL, Lingani C, Fernandez K, Cooper LV, Bita A, Tevi-Benissan C, Ronveaux O, Préziosi M-P, Stuart JM. Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data. Lancet Infect Dis. 2017 Aug;17(8):867–72. doi:10.1016/S1473-3099(17)30301-8.
- Bino S, Kakarriqi E, Xibinaku M, Ion-Nedelcu N, Bukli M, Emiroglu N, Uzicanin A. Measles-rubella mass immunization campaign in Albania, November 2000. J Infect Dis. 2003 May 15;187(Suppl 1):S223–9. doi:10.1086/368055.
- Centers for Disease Control and Prevention (CDC). Nationwide campaign for vaccination of adults against rubella and measles–costa Rica, 2001. MMWR Morb Mortal Wkly Rep. 2001 Nov 9;50(44):976–79.
- Hamkar R, Jalilvand S, Mokhtari-Azad T, Jelyani KN, Nategh R. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003. Am J Infect Control. 2006 Nov;34(9):588–92. doi:10.1016/j.ajic.2005.11.005.
- Pless RP, Bentsi-Enchill AD, Duclos P. Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues. J Infect Dis. 2003 May 15;187(Suppl 1):S291–8. doi:10.1086/368049.
- Ozawa S, Clark S, Portnoy A, Grewal S, Stack ML, Sinha A, Mirelman A, Franklin H, Friberg IK, Tam Y, et al. Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001–2020. Bull World Health Organ. 2017 Sep 1;95(9):629–38. doi:10.2471/BLT.16.178475.
- Dabbagh A, Patel MK, Dumolard L, Gacic-Dobo M, Mulders MN, Okwo-Bele JM, Kretsinger K, Papania MJ, Rota PA, Goodson JL. Progress toward regional measles elimination - worldwide, 2000–2016. MMWR Morb Mortal Wkly Rep. 2017 Oct 27;66(42):1148–53. doi:10.15585/mmwr.mm6642a6.
- Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect Dis. 2003;3:413–18. doi:10.1016/S1473-3099(03)00669-8.
- Yeung KHT, Duclos P, Nelson EAS, Hutubessy RCW. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis. 2017 Sep;17(9):974–80. doi:10.1016/S1473-3099(17)30390-0.
- Kyu HH, Mumford JE, Stanaway JD, Barber RM, Hancock JR, Vos T, Murray CJL, Naghavi M. Mortality from tetanus between 1990 and 2015: findings from the global burden of disease study 2015. BMC Public Health. 2017 Feb 8;17(1):179. doi:10.1186/s12889-017-4111-4.
- Diphtheria reported cases. [accessed 2018 Oct 17]. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencediphtheria.html.
- Aguado MT, Jodar L, Granoff D, Rabinovich R, Ceccarini C, Perkin GW. From epidemic meningitis vaccines for Africa to the meningitis vaccine project. Clin Infect Dis. 2015 Nov 15;61(Suppl 5):S391–5. doi:10.1093/cid/civ593.
- Babigumira JB, Morgan I, Levin A. Health economics of rubella: a systematic review to assess the value of rubella vaccination. BMC Public Health. 2013 Apr;29(13):406. doi:10.1186/1471-2458-13-406.
- Vynnycky E, Adams EJ, Cutts FT, Reef SE, Navar AM, Simons E, Yoshida L-M, Brown DWJ, Jackson C, Strebel PM, et al. Using seroprevalence and immunisation coverage data to estimate the global burden of congenital rubella syndrome, 1996–2010: A systematic review. PLoS One. 2016 Mar 10;11(3):e0149160. doi:10.1371/journal.pone.0149160.
- Hampton LM, Farley MM, Schaffner W, Thomas A, Reingold A, Harrison LH, Lynfield R, Bennett NM, Petit S, Gershman K, et al. Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines. J Infect Dis. 2012 Feb 1;205(3):401–11. doi:10.1093/infdis/jir755.
- Crowther-Gibson P, Cohen C, Klugman KP, de Gouveia L, von Gottberg A; Group for Enteric, Respiratory, and Meningeal Disease Surveillance in SouthAfrica (GERMS-SA). Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a settingwith high HIV prevalence, in the prevaccine era from 2003 to 2008. Antimicrob Agents Chemother. 2012 Oct;56(10):5088–95. doi:10.1128/AAC.06463-11.
- [accessed 2019 Mar 22]. https://www.dcvmn.org/Members-126.
- [accessed 2018 Sep 12]. http://www.who.int/immunization/policy/Immunization_routine_table1.pdf?ua=1.
- [accessed 17 Oct 2018]. https://www.unicef.org/supply/files/Table_of_Vaccine_Procurement_Volume_1996_2016.pdf.